All Stories

  1. Predictive value of left ventricular global function index in patients with aortic stenosis

    Article • Ultrasound & Functional Diagnostics, December 2023, Vidar, Ltd.

    Professor Dmitry Zateyshchikov

  2. Clinical and Genetic Landscape Hypertrophic Cardiomyopathy on a Russian Single-Center Cohort Study

    Article • Genes, November 2023, MDPI AG

    Professor Dmitry Zateyshchikov

  3. Cardiology 2023: the time of genetics

    Article • Russian Journal of Cardiology, October 2023, Silicea - Poligraf, LLC

    Professor Dmitry Zateyshchikov

  4. Assessment and modification of cardiovascular risk in non-cardiac surgery. Clinical guidelines 2023

    Article • Russian Journal of Cardiology, September 2023, Silicea - Poligraf, LLC

    Professor Dmitry Zateyshchikov

  5. Results of a pilot clinical trial of the safety and efficacy of an original glycoprotein IIb/IIIa receptor inhibitor in acute coronary syndrome

    Article • CARDIOVASCULAR THERAPY AND PREVENTION, September 2023, Silicea - Poligraf, LLC

    Professor Dmitry Zateyshchikov

  6. Lipoprotein (a) as a marker of hereditary lipid metabolism disorders in patients with early manifestation of coronary artery disease

    Article • Journal of clinical practice, July 2023, ECO-Vector LLC

    Professor Dmitry Zateyshchikov

  7. A rare variant in the TTR gene (p.E112K) is associated with systemic amyloidosis and a new symptom – skin hyperemia in response to ethanol intake: family segregation analysis, literature review, and a clinical case. Case report

    Article • Terapevticheskii arkhiv, May 2023, LLC Obyedinennaya Redaktsiya

    Professor Dmitry Zateyshchikov

  8. The levels of certain circulating microRNAs in hypertrophic cardiomyopathy are associated with echocardiographic parameters

    Article • Terapevticheskii arkhiv, May 2023, LLC Obyedinennaya Redaktsiya

    Professor Dmitry Zateyshchikov

  9. Mortality among kidney transplant recipients with SARS-CoV-2: a systematic review and meta-analysis of cohorts and clinical registries

    Article • March 2023, Bionika Media

    Professor Dmitry Zateyshchikov

  10. Mortality in kidney transplant recipients: a systematic review and meta-analysis of cohorts and clinical registries

    Article • March 2023, Bionika Media

    Professor Dmitry Zateyshchikov

  11. Novel Genes Involved in Hypertrophic Cardiomyopathy: Data of Transcriptome and Methylome Profiling

    Article • International Journal of Molecular Sciences, December 2022, MDPI AG

    Professor Dmitry Zateyshchikov

  12. Overlapping Phenotype of Adult-Onset ALPK3-Cardiomyopathy in the Setting of Two Novel Variants

    Article • Cardiology Research, December 2022, Elmer Press, Inc.

    Professor Dmitry Zateyshchikov

  13. A survey of physician opinions in Russia in the field of pharmacogenetics of cardiovascular disease

    Article • Pharmacogenomics, October 2022, Future Medicine

    Professor Dmitry Zateyshchikov

  14. Left ventricular global function index and peculiarities of daily blood pressure profile in patients with arterial hypertension

    Article • Russian Medicine, July 2022, ECO-Vector LLC

    Professor Dmitry Zateyshchikov

  15. Molecular cardiology: from decoding the genetic nature and mechanisms of the diseases development to the introduction into the clinic

    Article • Terapevticheskii arkhiv, May 2022, LLC Obyedinennaya Redaktsiya

    Professor Dmitry Zateyshchikov

  16. Practical guidelines for the diagnosis and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM or transthyretin cardiac amyloidosis)

    Article • Terapevticheskii arkhiv, May 2022, LLC Obyedinennaya Redaktsiya

    Professor Dmitry Zateyshchikov

  17. Prospects for Using Chromatography–Mass Spectrometry for the Determination of Lipids in Clinical Cardiolipidology

    Article • Journal of Analytical Chemistry, April 2022, Pleiades Publishing Ltd

    Professor Dmitry Zateyshchikov

  18. Circulating miR-499a-5p Is a Potential Biomarker of MYH7—Associated Hypertrophic Cardiomyopathy

    Article • International Journal of Molecular Sciences, March 2022, MDPI AG

    Professor Dmitry Zateyshchikov

  19. Сonsensus statement of Russian experts on the prevention, diagnosis and treatment of cardiotoxicity of anticancer therapy

    Article • Russian Journal of Cardiology, October 2021, Silicea - Poligraf, LLC

    Professor Dmitry Zateyshchikov

  20. Left ventricular global function index as a predictor of adverse cardiovascular events in patients with acute coronary syndrome

    Article • Kardiologiia, August 2021, APO Society of Specialists in Heart Failure

    Professor Dmitry Zateyshchikov

  21. Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy

    Article • European Heart Journal, July 2021, Oxford University Press (OUP)

    Professor Dmitry Zateyshchikov

  22. Visit-to-visit blood pressure variability in patients after acute coronary syndrome

    Article • Arterial’naya Gipertenziya (Arterial Hypertension), June 2021, Arterialnaya Gipertenziya

    Professor Dmitry Zateyshchikov

  23. Changes in plasma sphingolipid levels against the background of lipid-lowering therapy in patients with premature atherosclerosis

    Article • Bulletin of Russian State Medical University, June 2021, Pirogov Russian National Research Medical University

    Professor Dmitry Zateyshchikov

  24. Pitavastatin: focus on safety and drug interactions

    Article • Cardiosomatics, May 2021, ECO-Vector LLC

    Professor Dmitry Zateyshchikov

  25. Prevalence of hereditary factors in different age groups in patients with acute coronary syndrome

    Article • Russian Medicine, May 2021, ECO-Vector LLC

    Professor Dmitry Zateyshchikov

  26. Risk Stratification after an Acute Coronary Syndrome: Significance of Antithrombotic Therapy

    Article • Journal of Clinical Medicine, April 2021, MDPI AG

    Professor Dmitry Zateyshchikov

  27. Using the ORACLE Risk Score to Assess Hemorrhagic Risk in Patients with Acute Coronary Syndrome and Atrial Fibrillation

    Article • Rational Pharmacotherapy in Cardiology, March 2021, Stolichnaya Izdatelskaya Kompaniyaizdat

    Professor Dmitry Zateyshchikov

  28. RESULTS OF MULTICENTER MONITORING OF HEMOSTASIS PARAMETERS IN PATIENTS WITH COVID-19

    Article • PEDIATRIA Journal named after G N SPERANSKY, December 2020, Pediatria, Ltd.

    Professor Dmitry Zateyshchikov

  29. Bleeding risk scales in patients with acute coronary syndrome: place of the ORACUL scale

    Article • CARDIOVASCULAR THERAPY AND PREVENTION, November 2020, Silicea - Poligraf, LLC

    Professor Dmitry Zateyshchikov

  30. Can left ventricular global function index be a novel marker of unfavorable outcome in patients with acute coronary syndrome

    Article • European Heart Journal, November 2020, Oxford University Press (OUP)

    Professor Dmitry Zateyshchikov

  31. Contribution of electrocardiography to the diagnosis of cardiomyopathies and athletic heart syndrome

    Article • Russian Journal of Cardiology, September 2020, Silicea - Poligraf, LLC

    Professor Dmitry Zateyshchikov

  32. Inherited thrombophilia and venous thromboembolism: testing rules in clinical practice

    Article • Russian Journal of Cardiology, September 2020, Silicea - Poligraf, LLC

    Professor Dmitry Zateyshchikov

  33. Changes in the management of patients with acute coronary syndrome – have the disease outcomes changed?

    Article • Kardiologiia, September 2020, APO Society of Specialists in Heart Failure

    Professor Dmitry Zateyshchikov

  34. The Risk of Developing Ischemic Stroke in Patients After Exacerbation of Ischemic Heart Disease

    Article • Kardiologiia, September 2020, APO Society of Specialists in Heart Failure

    Professor Dmitry Zateyshchikov

  35. Recommendations of the Eurasian Arrhythmology Association (EURA) for the diagnosis and treatment of patients with arrhythmias and conduction disorders during the COVID-19 pandemic

    Article • Kardiologiia, May 2020, APO Society of Specialists in Heart Failure

    Professor Dmitry Zateyshchikov

  36. CYP2C9 and VKORC1 genotyping for the quality of long-standing warfarin treatment in Russian patients

    Article • The Pharmacogenomics Journal, February 2020, Springer Science + Business Media

    Professor Dmitry Zateyshchikov

  37. Bleeding rate and diagnostic value of different hemorrhagic risk scores in certain clinical groups of patients with acute coronary syndrome

    Article • Medical news of the North Caucasus, January 2020, Stavropol State Medical University

    Professor Dmitry Zateyshchikov

  38. Cardiology: genetics’ time

    Article • Consilium Medicum, January 2020, LLC Obyedinennaya Redaktsiya

    Professor Dmitry Zateyshchikov

  39. Lipidome features in patients with different probability of family hypercholesterolemia

    Article • Bulletin of Russian State Medical University, December 2019, Pirogov Russian National Research Medical University

    Professor Dmitry Zateyshchikov

  40. External validation of the ORACLE bleeding risk score using the database of the RECORD 3 registry

    Article • Kardiologiia, December 2019, APO Society of Specialists in Heart Failure

    Professor Dmitry Zateyshchikov

  41. Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF

    Article • The American Journal of Medicine, December 2019, Elsevier

    Professor Dmitry Zateyshchikov

  42. Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation

    Article • JACC Cardiovascular Interventions, December 2019, Elsevier

    Professor Dmitry Zateyshchikov

  43. Place of Prasugrel, P2Y12 receptor antagonist, in an early invasive treatment of patients with acute coronary syndrome (according to the results of multicenter randomized controlled trial ISAR-REACT 5)

    Article • Russian Journal of Cardiology, November 2019, Silicea - Poligraf, LLC

    Professor Dmitry Zateyshchikov

  44. A clinical case of hypertrophic cardiomyopathy and family hyperlipidemia

    Article • Journal of clinical practice, November 2019, ECO-Vector LLC

    Professor Dmitry Zateyshchikov

  45. Ticagrelor in Patients with Stable Coronary Disease and Diabetes

    Article • New England Journal of Medicine, September 2019, New England Journal of Medicine (NEJM/MMS)

    Professor Deepak L Bhatt, Prof HECTOR BUENO, Professor Dmitry Zateyshchikov

  46. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

    Article • The Lancet, September 2019, Elsevier

    Prof HECTOR BUENO, Professor Dmitry Zateyshchikov

  47. Participation of Sphingolipids in the Pathogenesis of Atherosclerosis

    Article • Kardiologiia, August 2019, APO Society of Specialists in Heart Failure

    Professor Dmitry Zateyshchikov

  48. Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF

    Article • American Heart Journal, July 2019, Elsevier

    Dr. Kenji Sadamatsu, Professor Dmitry Zateyshchikov

  49. VISIT-TO-VISIT BLOOD PRESSURE VARIABILITY AND RISK OF ALL-CAUSE DEATH

    Article • Journal of Hypertension, July 2019, Wolters Kluwer Health

    Professor Dmitry Zateyshchikov

  50. Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation

    Article • JAMA Cardiology, June 2019, American Medical Association (AMA)

    Dr. Kenji Sadamatsu, Professor Dmitry Zateyshchikov

  51. Influence of Microvascular Disease on Cardiovascular Events in Type 2 Diabetes

    Article • Journal of the American College of Cardiology, June 2019, Elsevier

    Professor Dmitry Zateyshchikov

  52. Bleeding risk factors in patients with acute coronary syndrome: data from observational studies ORACUL II

    Article • Russian Journal of Cardiology, April 2019, Silicea - Poligraf, LLC

    Professor Dmitry Zateyshchikov

  53. Physicians' guideline adherence is associated with long‐term heart failure mortality in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry

    Article • European Journal of Heart Failure, April 2019, Wiley

    Professor Dmitry Zateyshchikov

  54. Rationale, Design, and Baseline Characteristics of THEMIS: Effect of Ticagrelor on Health Outcomes in Diabetes Mellitus Patients Intervention Study

    Article • Clinical Cardiology, February 2019, Wiley

    Professor Deepak L Bhatt, Prof HECTOR BUENO, Professor Dmitry Zateyshchikov

  55. Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF Registry

    Article • Journal of the American Heart Association, February 2019, Wolters Kluwer Health

    Professor Zhi-Cheng JING, Dr. Kenji Sadamatsu, Professor Dmitry Zateyshchikov, Filipa Costa

  56. Early Risks of Death, Stroke/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial Fibrillation

    Article • Circulation, February 2019, Wolters Kluwer Health

    Professor Dmitry Zateyshchikov

  57. Psychosomatic Disorders in Patients with Pulmonary Hypertension: Impact on Treatment Adherence

    Article • Psikhiatriya, January 2019, Medical Informational Agency Publishers

    Professor Dmitry Zateyshchikov

  58. Characteristics and Management of Patients with Venous Thromboembolism: The GARFIELD-VTE Registry

    Article • Thrombosis and Haemostasis, December 2018, Thieme Publishing Group

    Professor Dmitry Zateyshchikov

  59. Risk Profile and 1-Year Outcome of Newly Diagnosed Atrial Fibrillation in Japan　― Insights From GARFIELD-AF ―

    Article • Circulation Journal, December 2018, Japanese Circulation Society

    Professor Dmitry Zateyshchikov

  60. Polymorphism of TNF gene in acute coronary syndrome patients: data from the registries ORACLE I and ORACLE II

    Article • Russian Journal of Cardiology, November 2018, Silicea - Poligraf, LLC

    Professor Dmitry Zateyshchikov

  61. Targeted sequencing in patients with clinically diagnosed hereditary lipid metabolism disorder and acute coronary syndrome

    Article • Bulletin of Russian State Medical University, November 2018, Pirogov Russian National Research Medical University

    Professor Dmitry Zateyshchikov

  62. Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

    Article • Indian Heart Journal, November 2018, Elsevier

    Dr. Kenji Sadamatsu, Professor Dmitry Zateyshchikov, Filipa Costa

  63. Treatment patterns in anticoagulant therapy in patients with newly diagnosed atrial fibrillation in Belgium: results from the GARFIELD-AF registry

    Article • Acta Cardiologica, October 2018, Taylor & Francis

    Professor Dmitry Zateyshchikov

  64. Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial

    Article • Journal of the American Society of Nephrology, October 2018, American Society of Nephrology

    Professor Dmitry Zateyshchikov

  65. Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness

    Article • New England Journal of Medicine, September 2018, New England Journal of Medicine (NEJM/MMS)

    Luis Jara-Palomares, MD Matteo Giorgi-Pierfranceschi, Professor Dmitry Zateyshchikov

  66. Screening of familial hypercholesterolemia among patients in age under 40 years old exposed by duplex scanning of carotid arteries, by the local registry data

    Article • Terapevticheskii arkhiv, September 2018, LLC Obyedinennaya Redaktsiya

    Professor Dmitry Zateyshchikov

  67. Polymorphism of ANXA2 gene may accelerate vulnerability and calcinosis in patients with coronary atherosclerosis

    Article • Atherosclerosis, August 2018, Elsevier

    Professor Dmitry Zateyshchikov

  68. IL-10 GENE POLYMORPHISM AND STROKE RISK IN PATIENTS WITH CORONARY ARTERY DISEASE

    Article • Journal of Hypertension, June 2018, Wolters Kluwer Health

    Professor Dmitry Zateyshchikov

  69. STRATEGY TO MINIMIZE THE BLEEDING RISKS IN PATIENTS WITH ATRIAL FIBRILLATION WHO RECEIVE COMBINED ANTITHROMBOTIC THERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION

    Article • Aterotromboz = Atherothrombosis, May 2018, Remedium, Ltd.

    Professor Dmitry Zateyshchikov

  70. Empagliflozin in women with type 2 diabetes and cardiovascular disease – an analysis of EMPA-REG OUTCOME®

    Article • Diabetologia, April 2018, Springer Science + Business Media

    Professor Dmitry Zateyshchikov

  71. Emergency care of patients receiving non-vitamin K antagonist oral anticoagulants

    Article • British Journal of Anaesthesia, April 2018, Elsevier

    Professor Dmitry Zateyshchikov

  72. GENETIC MARKERS OF MYOCARDIAL FIBROSIS: OPPORTUNITY TO PREDICT ADVERSE OUTCOMES IN AORTIC STENOSIS

    Article • Russian Journal of Cardiology, March 2018, Silicea - Poligraf, LLC

    Professor Dmitry Zateyshchikov

  73. IS IT SAFE TO SWITCH OAC IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION? RESULTS FROM A RE-DUAL PCI SUBANALYSIS

    Article • Journal of the American College of Cardiology, March 2018, Elsevier

    Professor Dmitry Zateyshchikov

  74. Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation

    Article • PLoS ONE, January 2018, PLOS

    Dr. Kenji Sadamatsu, Professor Dmitry Zateyshchikov

  75. Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease

    Article • Circulation, January 2018, Wolters Kluwer Health

    Professor Dmitry Zateyshchikov

  76. Family History of Cardiovascular Disease in Patients With Early Development of Acute Coronary Syndrome

    Article • Kardiologiia, January 2018, APO Society of Specialists in Heart Failure

    Professor Dmitry Zateyshchikov

  77. Possibilities of molecular biopsy in differential diagnosis of pulmonary arterial hypertension: case description and literature review

    Article • Medical news of the North Caucasus, January 2018, Stavropol State Medical University

    Professor Dmitry Zateyshchikov

  78. Risk of Stroke After Exacerbation of Ischemic Heart Disease: Data of 3‑Years Follow-up

    Article • Kardiologiia, January 2018, APO Society of Specialists in Heart Failure

    Professor Dmitry Zateyshchikov

  79. Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

    Article • The Lancet, January 2018, Elsevier

    Professor Dmitry Zateyshchikov

  80. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

    Article • The Lancet, January 2018, Elsevier

    Professor Dmitry Zateyshchikov

  81. Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry

    Article • European Heart Journal, December 2017, Oxford University Press (OUP)

    Dr. Kenji Sadamatsu, Professor Dmitry Zateyshchikov

  82. Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation

    Article • BMJ Open, December 2017, BMJ

    Dr. Kenji Sadamatsu, Professor Dmitry Zateyshchikov

  83. International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries

    Article • American Heart Journal, December 2017, Elsevier

    Professor Dmitry Zateyshchikov

  84. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

    Article • New England Journal of Medicine, October 2017, New England Journal of Medicine (NEJM/MMS)

    Professor Dmitry Zateyshchikov

  85. [PP.30.09] KIF6 GENE POLYMORPHISM IS ASSOCIATED WITH ARTERIAL RESISTANCE AND ATHEROSCLEROSIS IN PATIENTS WITH HYPERTENSION

    Article • Journal of Hypertension, September 2017, Wolters Kluwer Health

    Professor Dmitry Zateyshchikov

  86. Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF‐TIMI 48 Trial

    Article • Journal of the American Heart Association, August 2017, Wolters Kluwer Health

    Professor Dmitry Zateyshchikov, Professor Yuriy M. Sirenko

  87. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

    Article • New England Journal of Medicine, May 2017, New England Journal of Medicine (NEJM/MMS)

    Prof. Maciej Banach, Professor Thomas Munzel or Muenzel, Assoc. Prof. Elisabeta Badila, Professor Dmitry Zateyshchikov

  88. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients

    Article • New England Journal of Medicine, April 2017, New England Journal of Medicine (NEJM/MMS)

    Prof. J. David Spence, Dr DIEGO BELLIDO, Professor Dmitry Zateyshchikov

  89. Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk

    Article • Stroke, April 2017, Wolters Kluwer Health

    Professor Dmitry Zateyshchikov

  90. Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves

    Article • Circulation, March 2017, Wolters Kluwer Health

    Professor Dmitry Zateyshchikov, Professor Yuriy M. Sirenko

  91. Impact of gender on event rates at 1 year in patients with newly diagnosed non-valvular atrial fibrillation: contemporary perspective from the GARFIELD-AF registry

    Article • BMJ Open, March 2017, BMJ

    Dr. Kenji Sadamatsu, Professor Dmitry Zateyshchikov

  92. Empagliflozin and Cardiovascular Outcomes in Asian Patients With Type 2 Diabetes and Established Cardiovascular Disease　― Results From EMPA-REG OUTCOME® ―

    Article • Circulation Journal, January 2017, Japanese Circulation Society

    Professor Dmitry Zateyshchikov

  93. OUP accepted manuscript

    Article • European Heart Journal - Quality of Care and Clinical Outcomes, January 2017, Oxford University Press (OUP)

    Keith Fox, Professor Dmitry Zateyshchikov

  94. OUP accepted manuscript

    Article • European Heart Journal, January 2017, Oxford University Press (OUP)

    Professor Dmitry Zateyshchikov

  95. GENETIC POLYMORPHISM OF THE INFLAMMATORY CYTOKINE GENES AND ARTERIAL WALL PROPERTIES IN HYPERTENSIVE PATIENTS

    Article • Arterial’naya Gipertenziya (Arterial Hypertension), January 2017, Arterialnaya Gipertenziya

    Professor Dmitry Zateyshchikov

  96. PRIMARY (GENETICALLY DETERMINED) DILATION CARDIOMYOPATHY IN A PATIENT WITH NOVEL MUTATION OF LAMIN GENE: CLINICAL AND MORPHOLOGICAL MANAGEMENT

    Article • CARDIOVASCULAR THERAPY AND PREVENTION, January 2017, Silicea - Poligraf, LLC

    Professor Dmitry Zateyshchikov

  97. Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation

    Article • Circulation Arrhythmia and Electrophysiology, January 2017, Wolters Kluwer Health

    Professor Dmitry Zateyshchikov, Professor Yuriy M. Sirenko

  98. Evolving quality standards for large-scale registries: the GARFIELD-AF experience

    Article • European Heart Journal - Quality of Care and Clinical Outcomes, November 2016, Oxford University Press (OUP)

    Professor Dmitry Zateyshchikov

  99. Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: Real-world data from the GARFIELD-AF registry

    Article • International Journal of Cardiology, November 2016, Elsevier

    Professor Dmitry Zateyshchikov

  100. Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry

    Article • PLoS ONE, October 2016, PLOS

    Dr. Kenji Sadamatsu, Professor Dmitry Zateyshchikov

  101. Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation

    Article • Heart, September 2016, BMJ

    Dr. Kenji Sadamatsu, Professor Dmitry Zateyshchikov

  102. Multiple coronary fistulae into left ventricle as a rare cause of myocardial ischemia

    Article • Atherosclerosis, September 2016, Elsevier

    Professor Dmitry Zateyshchikov

  103. [PP.07.21] PARG GENE POLYMORPHISM IS ASSOCIATED THE DEVELOPMENT OF LEFT VENTRICULAR HYPERTROPHY IN ARTERIAL HYPERTENSION

    Article • Journal of Hypertension, September 2016, Wolters Kluwer Health

    Professor Dmitry Zateyshchikov

  104. Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events

    Article • Stroke, August 2016, Wolters Kluwer Health

    Director of the stroke unit, DMSci, clinical research associate professor Helle K. Iversen, Professor Dmitry Zateyshchikov, Professor Yuriy M. Sirenko

  105. Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes

    Article • New England Journal of Medicine, July 2016, New England Journal of Medicine (NEJM/MMS)

    Professor Dmitry Zateyshchikov

  106. Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF

    Article • European Heart Journal, June 2016, European Society of Cardiology

    Prof jean-pierre L bassand, Dr. Kenji Sadamatsu, Professor Dmitry Zateyshchikov

  107. A Novel Hypoxia-Inducible Factor−Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial

    Article • American Journal of Kidney Diseases, June 2016, Elsevier

    Professor Dmitry Zateyshchikov

  108. Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists

    Article • British Journal of Haematology, April 2016, Wiley

    Professor David Montes, Dr Helena DOMINGUEZ VALL-LAMORA, Dr. Kenji Sadamatsu, Professor Dmitry Zateyshchikov, Filipa Costa, Diego Chemello

  109. Cardioversion of Atrial Fibrillation in ENGAGE AF-TIMI 48

    Article • Clinical Cardiology, March 2016, Wiley

    Director of the stroke unit, DMSci, clinical research associate professor Helle K. Iversen, Professor Dmitry Zateyshchikov, Professor Yuriy M. Sirenko

  110. The use of optimal partitionings for multiparameter data analysis in clinical trials

    Article • Mathematical Biology and Bioinformatics, March 2016, Institute of Mathematical Problems of Biology of RAS (IMPB RAS)

    Professor Dmitry Zateyshchikov

  111. Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF

    Article • Journal of the American Heart Association, March 2016, Wolters Kluwer Health

    Professor Malcolm R Macleod, Professor Dmitry Zateyshchikov, Professor Yuriy M. Sirenko

  112. Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction With ST-Segment Elevation After Prehospital Thrombolysis

    Article • Kardiologiia, February 2016, Bionika Media

    Professor Dmitry Zateyshchikov

  113. Using Necrosis Biomarkers for the Early Diagnosis of Myocardial Infarction in Modern Conditions

    Article • Kardiologiia, January 2016, Bionika Media

    Professor Dmitry Zateyshchikov

  114. Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME®trial

    Article • European Heart Journal, January 2016, European Society of Cardiology

    Professor Dmitry Zateyshchikov

  115. Early Systolic Dysfunction of Left Ventricular Myocardium Is Reflected On Electrocardiogram of Patients With Aortic Stenosis

    Article • Kardiologiia, December 2015, Bionika Media

    Professor Dmitry Zateyshchikov

  116. Genetic Features of Factors of Inflammation and Fibrosis – Possible Common Pathway of Formation of Predisposition to Atrial Fibrillation and Chronic Obstructive Pulmonary Disease

    Article • Kardiologiia, December 2015, Bionika Media

    Professor Dmitry Zateyshchikov

  117. MOLECULAR-GENETIC FACTORS, ASSOCIATED WITH AORTIC STENOSIS DEVELOPMENT

    Article • Russian Journal of Cardiology, November 2015, Silicea - Poligraf, LLC

    Professor Dmitry Zateyshchikov

  118. Atrial Fibrillation in Patients With Chronic Obstructive Pulmonary Disease Is Associated With Polymorphism of Interleukin 6 Gene

    Article • Kardiologiia, November 2015, Bionika Media

    Professor Dmitry Zateyshchikov

  119. GENETIC POLYMORPHISM OF INFLAMMATORY FACTORS IS ASSOCIATED WITH THROMBOEMBOLIC COMPLICATIONS OF ATRIAL FIBRILLATION

    Article • Russian Journal of Cardiology, November 2015, Silicea - Poligraf, LLC

    Professor Dmitry Zateyshchikov

  120. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

    Article • New England Journal of Medicine, November 2015, New England Journal of Medicine (NEJM/MMS)

    Chief Director, Internal Medicine Department & Diabetes Center "George Papanikolaou" General Hospital IAKOVOS AVRAMIDIS, Professor Dmitry Zateyshchikov

  121. THE REVOLUTION, WE HAVE ALMOST OVERSLEPT

    Article • Russian Journal of Cardiology, November 2015, Silicea - Poligraf, LLC

    Professor Dmitry Zateyshchikov

  122. Biomarkers in Heart Failure: Apelin Level Is not Associated With Presence and Severity of the Disease

    Article • Kardiologiia, February 2015, Bionika Media

    Professor Dmitry Zateyshchikov

  123. Does Sex Affect Anticoagulant Use for Stroke Prevention in Nonvalvular Atrial Fibrillation?: The Prospective Global Anticoagulant Registry in the FIELD-Atrial Fibrillation

    Article • Circulation Cardiovascular Quality and Outcomes, February 2015, Wolters Kluwer Health

    Dr Helena DOMINGUEZ VALL-LAMORA, Dr. Kenji Sadamatsu, Professor Dmitry Zateyshchikov, Filipa Costa, Diego Chemello

  124. Late Silent Stent Abscess

    Article • Cardiology, January 2015, Karger Publishers

    Professor Dmitry Zateyshchikov

  125. Chronic Thromboembolic Pulmonary Hypertension

    Article • Deutsches Ärzteblatt international, December 2014, Deutscher Arzte-Verlag GmbH

    Professor Dmitry Zateyshchikov

  126. Current Aspects of Fibrinolysis

    Article • Kardiologiia, November 2014, Bionika Media

    Professor Dmitry Zateyshchikov

  127. Сhronic Thromboembolic Pulmonary Hypertension

    Article • Kardiologiia, November 2014, Bionika Media

    Professor Dmitry Zateyshchikov

  128. Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome

    Article • JAMA, September 2014, American Medical Association (AMA)

    Jerome Chin, Professor Dmitry Zateyshchikov, Filipa Costa

  129. Cerebrovascular Events in 21 105 Patients With Atrial Fibrillation Randomized to Edoxaban Versus Warfarin

    Article • Stroke, August 2014, Wolters Kluwer Health

    Professor Dmitry Zateyshchikov, Professor Yuriy M. Sirenko

  130. An intuitive risk factors search algorithm: usage of the Bayesian network technique in personalized medicine

    Article • Journal of Applied Statistics, July 2014, Taylor & Francis

    Mr Igor A Savkin, Professor Dmitry Zateyshchikov

  131. Laboratory Monitoring of the Efficacy and Safety of Anticoagulants

    Article • Kardiologiia, May 2014, Bionika Media

    Professor Dmitry Zateyshchikov

  132. Degenerative Aortic Stenosis: Prediction of Poor Prognosis by 2D Left Ventricular Longitudinal Strain in Non-Operated Patients

    Article • Kardiologiia, February 2014, Bionika Media

    Professor Dmitry Zateyshchikov

  133. Dabigatran in Prevention of Stroke in Atrial Fibrillation: Three Years of Clinical Application

    Article • Kardiologiia, February 2014, Bionika Media

    Professor Dmitry Zateyshchikov

  134. Varespladib and Cardiovascular Events in Patients With an Acute Coronary Syndrome

    Article • JAMA, January 2014, American Medical Association (AMA)

    Professor Dmitry Zateyshchikov

  135. Edoxaban versus Warfarin in Patients with Atrial Fibrillation

    Article • New England Journal of Medicine, November 2013, New England Journal of Medicine (NEJM/MMS)

    Professor Malcolm R Macleod, Assoc. Prof. Elisabeta Badila, Director of the stroke unit, DMSci, clinical research associate professor Helle K. Iversen, Professor Dmitry Zateyshchikov, Professor Yuriy M. Sirenko

  136. Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization

    Article • New England Journal of Medicine, October 2012, New England Journal of Medicine (NEJM/MMS)

    Professor Antonis S Manolis, Professor Dmitry Zateyshchikov

  137. ISSUES OF ANTICOAGULANT TREATMENT MANAGEMENT

    Article • Journal of clinical practice, September 2012, ECO-Vector LLC

    Professor Dmitry Zateyshchikov

  138. WARFARIN IN PATIENTS WITH CARDIOEMBOLIC STROKE

    Article • Rational Pharmacotherapy in Cardiology, January 2012, Stolichnaya Izdatelskaya Kompaniyaizdat

    Professor Dmitry Zateyshchikov

  139. Polymorphic markers Ala455Val of the THBD gene and Arg353Gln of the F7 gene and genetic association with unfavorable outcomes of coronary atherosclerosis in patients with a history of acute ischemic heart disease

    Article • Russian Journal of Genetics, October 2011, Pleiades Publishing Ltd

    Professor Dmitry Zateyshchikov

  140. Rationale, design, and results from RENO-DEFEND 1: A randomized, dose-finding study of the selective A1 adenosine antagonist SLV320 in patients hospitalized with acute heart failure

    Article • American Heart Journal, June 2011, Elsevier

    Professor Dmitry Zateyshchikov

  141. 602 ASSOCIATION OF POLYMORPHIC MARKERS C3386A OF HMGCR GENE AND G(-198)A OF FDFT1 GENE WITH CORONARY ARTERY DISEASE

    Article • Atherosclerosis Supplements, June 2011, Elsevier

    Professor Dmitry Zateyshchikov

  142. 611 DEVELOPMENT OF GENDER PRESPECIFIED PREDICTION MODEL BASED ON BAYESIAN BELIEVE NETWORKS METHOD FOR RISK ESTIMATION AFTER ACUTE CORONARY SYNDROME

    Article • Atherosclerosis Supplements, June 2011, Elsevier

    Professor Dmitry Zateyshchikov

  143. 869 DEVELOPMENT OF GENDER PRESPECIFIED PREDICTIVE MODEL BASED ON BAYESIAN BELIEVE NETWORKS METHOD FOR UNFAVOURABLE OUTCOMES AFTER ACUTE CORONARY SYNDROME

    Article • Atherosclerosis Supplements, June 2011, Elsevier

    Professor Dmitry Zateyshchikov

  144. 634 GENDER DEPENDENT ASSOCIATION BETWEEN KIF6 POLYMORPHISM AND RISK OF UNFAVORABLE OUTCOME IN PATIENTS SURVIVED ACUTE CORONARY SYNDROME

    Article • Atherosclerosis Supplements, June 2011, Elsevier

    Professor Dmitry Zateyshchikov

  145. 639 POLYMORPHIC MARKERS OF THBD AND PROC GENES AND GENETIC PREDISPOSITION TO UNFAVOURABLE OUTCOMES IN PATIENTS AFTER ACUTE CORONARY SYNDROME

    Article • Atherosclerosis Supplements, June 2011, Elsevier

    Professor Dmitry Zateyshchikov

  146. Ispol'zovanie rozuvastatina v lechenii bol'nykh gruppy riska sosudistykh oslozhneniy ateroskleroza.

    Article • Systemic Hypertension, March 2011, Intermedservice Ltd

    Professor Dmitry Zateyshchikov

  147. PECULIAR PROPERTIES OF ANTITHROMBOTIC THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION. IS IT POSSIBLE TO DO THE TREATMENT SAFE?

    Article • Rational Pharmacotherapy in Cardiology, January 2011, Stolichnaya Izdatelskaya Kompaniyaizdat

    Professor Dmitry Zateyshchikov

  148. Rolofylline, an Adenosine A1−Receptor Antagonist, in Acute Heart Failure

    Article • New England Journal of Medicine, October 2010, New England Journal of Medicine (NEJM/MMS)

    Professor John GF Cleland, Professor Dmitry Zateyshchikov

  149. The polymorphisms G(−174)C in IL6 gene and G(−1082)A in IL10 gene are associated with poor outcomes in patients with acute coronary syndrome

    Article • Molecular Biology, October 2010, Pleiades Publishing Ltd

    Professor Dmitry Zateyshchikov

  150. Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial

    Article • The Lancet, August 2010, Elsevier

    Professor Philippe Gabriel STEG, Professor Dmitry Zateyshchikov

  151. Association of the polymorphic markers G(−455)A in the FGB gene and C(−1654)T in the PROC gene with hereditary predisposition to unfavourable outcome in patients with history of acute coronary syndrome

    Article • Molecular Biology, August 2010, Pleiades Publishing Ltd

    Professor Dmitry Zateyshchikov

  152. MS217 ASSOCIATION OF THE CHOLESTEROL ESTER TRANSFER PROTEIN GENE (CETP) WITH CORONARY ARTERY DISEASE

    Article • Atherosclerosis Supplements, June 2010, Elsevier

    Professor Dmitry Zateyshchikov

  153. MS216 IL6 AND IL10 GENES ARE ASSOCIATED WITH UNFAVOURABLE OUTCOMES IN PATIENTS WITH ACUTE CORONARY SYNDROME

    Article • Atherosclerosis Supplements, June 2010, Elsevier

    Professor Dmitry Zateyshchikov

  154. Association of the CYBA, PPARGC1A, PPARG3, and PPARD gene variants with coronary artery disease and metabolic risk factors of coronary atherosclerosis in a Russian population

    Article • Heart and Vessels, May 2010, Springer Science + Business Media

    Professor Dimitry A Chistiakov, Professor Dmitry Zateyshchikov

  155. Advanced age, low left atrial appendage velocity, and Factor V promoter sequence variation as predictors of left atrial thrombosis in patients with nonvalvular atrial fibrillation

    Article • Journal of Thrombosis and Thrombolysis, January 2010, Springer Science + Business Media

    Professor Dimitry A Chistiakov, Professor Dmitry Zateyshchikov

  156. Design and Rationale of the PROTECT Study: A Placebo-controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effe...

    Article • Journal of Cardiac Failure, January 2010, Elsevier

    Professor Dmitry Zateyshchikov

  157. THE MODERN ASPECTS OF CLOPIDOGREL USE

    Article • Rational Pharmacotherapy in Cardiology, January 2010, Stolichnaya Izdatelskaya Kompaniyaizdat

    Professor Dmitry Zateyshchikov

  158. Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

    Article • New England Journal of Medicine, September 2009, New England Journal of Medicine (NEJM/MMS)

    Professor Philippe Gabriel STEG, Professor Antonis S Manolis, Professor Dmitry Zateyshchikov

  159. Chronic Thromboembolic Pulmonary Hypertension

    Article • July 2009, Taylor & Francis

    Professor Dmitry Zateyshchikov

  160. The PROTECT Pilot Study: A Randomized, Placebo-Controlled, Dose-Finding Study of the Adenosine A1 Receptor Antagonist Rolofylline in Patients With Acute Heart Failure and Renal Impairment

    Article • Journal of Cardiac Failure, October 2008, Elsevier

    Professor Dmitry Zateyshchikov

  161. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

    Article • The Lancet, September 2008, Elsevier

    Professor Philippe Gabriel STEG, Professor Antonis S Manolis, Professor Dmitry Zateyshchikov

  162. Safety and Efficacy of Outpatient Nesiritide in Patients With Advanced Heart Failure

    Article • Circulation Heart Failure, May 2008, Wolters Kluwer Health

    Professor Dmitry Zateyshchikov

  163. The BEAUTIFUL Study: Randomized Trial of Ivabradine in Patients with Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction – Baseline Characteristics of the Study Population

    Article • Cardiology, December 2007, Karger Publishers

    Professor Antonis S Manolis, Professor Dmitry Zateyshchikov

  164. Association of GNB3 gene C825T polymorphism with coronary heart disease

    Article • Russian Journal of Genetics, August 2007, Pleiades Publishing Ltd

    Professor Dmitry Zateyshchikov

  165. Association of CYP2D6 and ADRB1 genes with hypotensive and antichronotropic action of betaxolol in patients with arterial hypertension

    Article • Fundamental and Clinical Pharmacology, July 2007, Wiley

    Professor Dmitry Zateyshchikov

  166. Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes

    Article • New England Journal of Medicine, April 2006, New England Journal of Medicine (NEJM/MMS)

    Professor Thomas Munzel or Muenzel, Professor Dmitry Zateyshchikov

  167. Mo-P6:387 Genetic predisposition to early onset of coronary artery disease in Russian patients

    Article • Atherosclerosis Supplements, January 2006, Elsevier

    Professor Dmitry Zateyshchikov

  168. Mo-P6:455 Genetic predisposition to unfavourable outcomes in patients with unstable angina

    Article • Atherosclerosis Supplements, January 2006, Elsevier

    Professor Dmitry Zateyshchikov

  169. W03-P-008 Genetic basis of inherited predisposition to coronary artery disease

    Article • Atherosclerosis Supplements, April 2005, Elsevier

    Professor Dmitry Zateyshchikov

  170. Association of Polymorphic Marker A1/A2 of Gene ITGB3 with Coronary Artery Disease and Myocardial Infarction

    Article • Russian Journal of Genetics, October 2004, Springer Science + Business Media

    Professor Dmitry Zateyshchikov

  171. Association of Polymorphic Marker G(–455)A of Gene FGB with Coronary Artery Disease

    Article • Russian Journal of Genetics, October 2004, Springer Science + Business Media

    Professor Dmitry Zateyshchikov

  172. ASSOCIATION OF THE POLYMORPHIC MARKERS OF MTHFR, EDN1, CYP11B2, PPARA AND PPARG2 GENES WITH THE SEVERITY OF ESSENTIAL HYPERTENSION

    Article • Journal of Hypertension, June 2004, Wolters Kluwer Health

    Professor Dmitry Zateyshchikov

  173. Article • Molecular Biology, January 2003, Springer Science + Business Media

    Professor Dmitry Zateyshchikov

  174. Article • Molecular Biology, January 2003, Springer Science + Business Media

    Professor Dmitry Zateyshchikov

  175. Article • Russian Journal of Genetics, January 2000, Springer Science + Business Media

    Professor Dmitry Zateyshchikov

  176. Anticoagulant properties of the endothelium studied by the standard venous occlusion test

    Article • Bulletin of Experimental Biology and Medicine, December 1992, Springer Science + Business Media

    Professor Dmitry Zateyshchikov